Does ROSUVASTATIN Cause Dyspnoea? 2,832 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 2,832 reports of Dyspnoea have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 7.8% of all adverse event reports for ROSUVASTATIN.
2,832
Reports of Dyspnoea with ROSUVASTATIN
7.8%
of all ROSUVASTATIN reports
47
Deaths
999
Hospitalizations
How Dangerous Is Dyspnoea From ROSUVASTATIN?
Of the 2,832 reports, 47 (1.7%) resulted in death, 999 (35.3%) required hospitalization, and 164 (5.8%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 2,832 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
Drug hypersensitivity (1,669)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which ROSUVASTATIN Alternatives Have Lower Dyspnoea Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN